{"schema_version":"secwatch.filing_event.v1","accession":"0001555280-25-000259","form_type":"8-K","ticker":"ZTS","cik":"0001555280","company_name":"Zoetis Inc.","filed_at":"2025-08-05T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.339955+00:00","generated_at":"2026-05-17T20:39:52.835805+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Zoetis Q2 revenue $2.5B (+4% reported, +8% organic); raises FY2025 guidance","bullets":["Reported net income $718M ($1.61 diluted EPS), up 15% YoY; adjusted EPS $1.76, up 13%.","U.S. segment revenue $1.4B (+4% reported, +7% organic); companion animal product sales up 9%.","International segment revenue $1.1B (+3% reported, +9% organic); livestock sales up 10% organic.","Raised FY2025 revenue guidance to $9.45-9.60B (organic growth 6.5-8.0%); adjusted EPS $6.30-6.40.","Simparica Trio gained new label in Japan; avian influenza vaccine conditionally licensed for U.S. dairy cattle."],"urls":{"canonical":"https://secwatch.observer/filing/0001555280-25-000259","json":"https://secwatch.observer/filing/0001555280-25-000259.json","markdown":"https://secwatch.observer/filing/0001555280-25-000259.md","text":"https://secwatch.observer/filing/0001555280-25-000259.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1555280/000155528025000259/0001555280-25-000259-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1555280/000155528025000259/zts-20250805.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T20:39:52.835805+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}